Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
New optical imaging technology evaluated to diagnose tumor malignancy
October 6th, 2005
A new optical imaging technology was evaluated to assess its effectiveness to diagnose tumor malignancy. According to a recently published article in Academic Radiology, "Near-infrared (NIR) technology appears promising as a noninvasive technique for breast cancer screening and diagnosis. The technology capitalizes on the relative transparency of human tissue in this spectral range and its sensitivity to the main components of the breast: water, lipid, and hemoglobin." "In this study," X. Intes reports "quantitative measurements of these components and the functional contrast between healthy and diseased tissue. A four-wavelength time domain...
Source: Women's Health Weekly (2005-10-06)
|
